Topic: Sackler Family

The Supreme Court ruled that the Sackler family cannot use Purdue Pharma's bankruptcy to escape personal liability for the opioid crisis. Additionally, the hosts express anticipation for a ruling on "Chevron deference," which could significantly limit the power of federal administrative agencies.

Johnson & Johnson reached a $700 million settlement over allegations of misleading consumers about the safety of its talcum-based baby powder. Additionally, the company agreed to pay $150 million to Washington State to settle claims related to its role in the opioid crisis. These settlements follow the multi-billion dollar bankruptcy of Purdue Pharma and the Sackler family's legal battles, highlighting ongoing accountability efforts within the pharmaceutical industry.

The hosts discuss the Netflix series "Painkiller" and the previous show "Dopesick," characterizing them as efforts to whitewash the broader pharmaceutical industry by focusing all blame on the Sackler family. They argue that while the Sacklers were responsible for the opioid crisis, other major companies like Johnson & Johnson have paid significantly larger fines for similar malfeasance that receives less media dramatization.

The Supreme Court has temporarily blocked a $6 billion settlement for Purdue Pharma that would have shielded the Sackler family from future civil lawsuits. The Biden administration objected to the deal's liability protections. The hosts compare the Sacklers to larger pharmaceutical companies like Johnson & Johnson, suggesting the family is being used as a scapegoat for the broader opioid crisis.

A federal appeals court cleared a bankruptcy deal for Purdue Pharma that shields the Sackler family from future civil lawsuits related to the opioid crisis. As part of the settlement, the family will pay $6 billion and relinquish control of the company. The ruling has been controversial, as it provides legal immunity to the owners of the company primarily blamed for the OxyContin epidemic.

A federal bankruptcy judge approved a controversial deal allowing the Sackler family to gain immunity from future opioid lawsuits in exchange for a $4 billion payment. The deal allows the family to keep billions of their fortune while stopping hundreds of civil lawsuits. The hosts describe this as a "scam of scams" that protects the family without them personally filing for bankruptcy.

The Sackler family's $6 billion settlement for the opioid crisis is contrasted with a $26 billion fine for Johnson & Johnson and other distributors. Meanwhile, Austin, Texas, is experiencing a surge in fentanyl-related overdoses, with 12 people hospitalized in a single night. Police have significantly increased their use of Narcan to treat victims.

The Senate confirmed Robert Califf as FDA Commissioner with support from five Republicans, despite his past financial ties to the pharmaceutical industry. The hosts criticize tech journalist Kara Swisher for interviewing an author about the Sackler family's opioid corruption without acknowledging similar patterns in current pharmaceutical mandates.

The U.S. records over 100,000 drug overdose deaths in a 12-month period, driven largely by synthetic fentanyl. While the Sackler family and Purdue Pharma face fines for their role in the OxyContin epidemic, critics argue the focus on them distracts from other major manufacturers like Johnson & Johnson. NPR reports emphasize Mexican drug cartels and pandemic disruptions as primary drivers of the surge.

The Hulu series Dope Sick, starring Michael Keaton, depicts the history of the Sackler family and the marketing of OxyContin. The narrative highlights how the term "breakthrough pain" was allegedly invented by pharmaceutical companies to justify doubling dosages when time-release medications failed. This historical marketing tactic is compared to the modern use of the term "breakthrough cases" in the pharmaceutical industry.

The rapid rollout of COVID-19 vaccines is attributed to pharmaceutical greed and political motivations to prevent a Donald Trump election victory. Critics claim the Great Reset agenda utilized faulty PCR testing to implement voting changes and social controls. Despite these efforts, vaccine hesitancy is reportedly rising as doctors and the public begin to question the necessity of vaccinating children and those with natural immunity.

A federal bankruptcy judge approved a controversial settlement for Purdue Pharma that grants the Sackler family immunity from future opioid-related lawsuits. The deal requires the family to pay $4 billion but allows them to maintain their private fortunes and admit no wrongdoing. The immunity extends to hundreds of other entities, a move criticized by several state attorneys general as a dangerous precedent for corporate accountability.

McKinsey & Company agreed to a $573 million settlement for its role in "turbocharging" the sales of OxyContin for Purdue Pharma. The consulting firm reportedly instructed sales reps on how to bypass FDA restrictions and target doctors to increase prescriptions. This story has received limited coverage in mainstream media, likely due to the firm's deep ties to the CIA and political figures like Pete Buttigieg.

A wide-ranging critique of institutional corruption covers the Sackler family's role in the opioid crisis, the "doctored evidence" of the White Helmets in Syria, and the influence of China on the NBA and Apple. Bill Gates is singled out for his promotion of processed meats and his frequent media appearances. The rise of independent commentators like Tim Pool is attributed to a general loss of faith in the medical community, central banks, and mainstream media.

The Attorney General of Massachusetts files a lawsuit against the billionaire Sackler family, owners of Purdue Pharma, for their role in the opioid epidemic. Court documents allege that Richard Sackler encouraged the company to blame "addicts" for the crisis while aggressively pushing OxyContin sales. The hosts also discuss the side effects of the drug, noting that high doses reportedly contributed to radio host Rush Limbaugh's deafness.

Purdue Pharma announced it will stop promoting OxyContin to doctors following a wave of lawsuits from states and municipalities over the opioid epidemic. The Sackler family, owners of the private company, have amassed an estimated $35 billion to $40 billion in sales since the drug's release in 1996. Critics view the cessation of marketing as a PR move to soften public sentiment as the company faces allegations of duping the public about the drug's addictive nature.